DK1581227T3 - Fremgangsmåde til behandling af nyresvigt - Google Patents

Fremgangsmåde til behandling af nyresvigt

Info

Publication number
DK1581227T3
DK1581227T3 DK04700048T DK04700048T DK1581227T3 DK 1581227 T3 DK1581227 T3 DK 1581227T3 DK 04700048 T DK04700048 T DK 04700048T DK 04700048 T DK04700048 T DK 04700048T DK 1581227 T3 DK1581227 T3 DK 1581227T3
Authority
DK
Denmark
Prior art keywords
treatment
renal failure
procedure
failure
levosimendan
Prior art date
Application number
DK04700048T
Other languages
Danish (da)
English (en)
Inventor
Heimo Haikala
Matti Kivikko
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Application granted granted Critical
Publication of DK1581227T3 publication Critical patent/DK1581227T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
DK04700048T 2003-01-03 2004-01-02 Fremgangsmåde til behandling af nyresvigt DK1581227T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20030015A FI20030015A0 (fi) 2003-01-03 2003-01-03 Menetelmä munuaisten vajaatoiminnan hoitamiseksi
PCT/FI2004/000002 WO2004060375A1 (fr) 2003-01-03 2004-01-02 Procede pour traiter l'insuffisance renale

Publications (1)

Publication Number Publication Date
DK1581227T3 true DK1581227T3 (da) 2007-04-23

Family

ID=8565258

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04700048T DK1581227T3 (da) 2003-01-03 2004-01-02 Fremgangsmåde til behandling af nyresvigt

Country Status (13)

Country Link
US (1) US20060166994A1 (fr)
EP (1) EP1581227B1 (fr)
JP (1) JP4588016B2 (fr)
AT (1) ATE355063T1 (fr)
CA (1) CA2511735C (fr)
CY (1) CY1106586T1 (fr)
DE (1) DE602004005000T2 (fr)
DK (1) DK1581227T3 (fr)
ES (1) ES2281775T3 (fr)
FI (1) FI20030015A0 (fr)
PT (1) PT1581227E (fr)
SI (1) SI1581227T1 (fr)
WO (1) WO2004060375A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004270162B2 (en) 2003-08-28 2010-05-13 Nicox S.A. Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
FI20040674A0 (fi) 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
CA2597460A1 (fr) 2005-02-24 2006-08-31 Nitromed, Inc. Compositions et composes diuretiques renforcateurs d'oxyde nitrique, et leurs procedes d'utilisation
WO2021001601A1 (fr) 2019-07-01 2021-01-07 Orion Corporation Procédés d'administration de(r)-n-[4-(1,4,5,6-tétrahydro-6-oxo-3-pyridazinyl)phényl]acétamide
AU2020408323A1 (en) 2019-12-16 2022-08-11 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
JP3131845B2 (ja) * 1991-06-12 2001-02-05 帝国臓器製薬株式会社 慢性心不全治療剤
ES2263557T3 (es) * 2000-01-31 2006-12-16 Pfizer Products Inc. Uso de agonistas selectivos del receptor 4(ep4) de prostablandinas (pge2) para el tratamiento de insuficiencia renal aguda y cronica.

Also Published As

Publication number Publication date
EP1581227B1 (fr) 2007-02-28
JP2006515348A (ja) 2006-05-25
WO2004060375A1 (fr) 2004-07-22
JP4588016B2 (ja) 2010-11-24
CA2511735C (fr) 2011-09-20
DE602004005000D1 (de) 2007-04-12
ES2281775T3 (es) 2007-10-01
ATE355063T1 (de) 2006-03-15
SI1581227T1 (sl) 2007-06-30
FI20030015A0 (fi) 2003-01-03
PT1581227E (pt) 2007-03-30
EP1581227A1 (fr) 2005-10-05
DE602004005000T2 (de) 2007-11-15
CY1106586T1 (el) 2012-01-25
CA2511735A1 (fr) 2004-07-22
US20060166994A1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
DK1940918T3 (da) Dimercaptanterminerede polythioetherpolymerer og fremgangsmåder til at fremstille og anvende samme
NO20053993D0 (no) Kjemiske forbindelser.
NO20080622L (no) Disykloalkylurea-glukokinase aktivatorer
BRPI0718146A2 (pt) Dispositivos de infusão e métodos
NO20052887D0 (no) Pyridazinonderivater som GSK-3Beta inhibitorer.
EA200701802A1 (ru) Имидазо(1,2-а)пиридиновые соединения в качестве ингибиторов vegf-r2
NO20081042L (no) PPAR aktive forbindelser
DK1549341T3 (da) Mod vævsfaktor rettede antistoffer som antikoagulanter
DK1633697T3 (da) Fremgangsmåde til fremstilling af substituerede 3-aryl-butyl-aminforbindelser
DK1638443T3 (da) Isoformer af hjerne-natriuretisk peptid
NO20083147L (no) Anti-OX40L-antistoffer og fremgangsmater for anvendelse av disse
NL1027608A1 (nl) Automatisch uitlijnend scintillator-collimatorsamenstel.
DK1248867T3 (da) Selektiv elektrokemisk reduktion af halogenerede 4-aminopicolinsyrer
DK1773420T3 (da) Anvendelse af gingivale fibroblaster til vaskulær celleterapi
ITRE20030089A1 (it) Gruppo autocentrante perfezionato.
UY28344A1 (es) Nuevos compuestos
CY1106586T1 (el) Μια μεθοδος για την θεραπευτικη αγωγη νεφρικης ανεπαρκειας
UY28345A1 (es) Compuestos novedosos
NL1025769A1 (nl) Projectiesysteem.
IS7705A (is) 4-(3,5-Dísýanófenoxý) pýrasól afleiður til notkunar sem bakritunarstillar við meðhöndlun á m.a. eyðniveirunni
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
DE602004030231D1 (de) Pyrimidinonverbindungen als calcilytica
ITTO20030850A1 (it) Procedimento per la preparazione di 4-ammino-3,5-dicloro-benzotrifloruro.
TW200635584A (en) Use of PPAR agonists for the treatment of congestive heart failure
DK1521752T3 (da) Makrocykliske forbindelser til behandling af cancer